The Journal of Allergy and Clinical Immunology: In Practice
Review and Feature ArticleSevere Asthma in Children
Section snippets
Severe Asthma in Children Is Different than Adult Disease
Extrapolating adult severity classifications to children is difficult for a number of reasons. Adults with asthma are more likely to exhibit a persistent pattern, whereas children may have a pattern of rapidly evolving, frequent, and often severe exacerbations. Children have severe exacerbations triggered by viral infections and/or allergen exposure that can result in health care utilization but then often remain asymptomatic between these episodes.10, 11 Phenotypes of severe asthma in children
Epidemiology of Severe Asthma
Epidemiologic studies have described risk factors for severe asthma and airway hyperresponsiveness. Many children with severe asthma present when school age (range, 6-11 years); however, they report the onset of asthma symptoms earlier in childhood (first 3 years of life) than children with mild-to-moderate asthma (5 years mean).3, 29 Another risk factor for asthma and severe airway hyperresponsiveness may be lower lung function present shortly after birth. Infants with the lowest pulmonary
Severe Asthma Definitions
Although several definitions of “severe asthma” have been proposed, no single definition has gained universal acceptance due to the complex nature of the disease and the lack of validated criterion standards for diagnosis. To further complicate matters, “asthma” itself is a highly heterogeneous condition that remains poorly understood in children. In a recent review of large cohorts of school-age children with asthma, 122 publications yielded 60 different operational definitions of asthma,
Heterogeneity of Severe Asthma in Children
It is increasingly recognized that severe asthma is a highly heterogeneous disorder associated with a number of clinical and inflammatory phenotypes that can be assessed through detailed analysis of induced sputum, bronchoalveolar lavage, or endobronchial biopsy.44, 45, 46, 47 Although this research is incomplete, particularly in children with severe asthma, 3 phenotypes of airway inflammation have been described: (1) eosinophilic inflammation,48, 49 (2) paucigranulocytic inflammation,48, 49
Differential Diagnosis
Several diseases that mimic asthma should be considered during the evaluation of a child with severe asthma (Table II). These include the following: structural airway abnormality, intrabronchial obstruction, aspiration, gastroesophageal reflux with or without recurrent microaspiration, cystic fibrosis, ciliary dyskinesia, immune dysfunction, bronchiectasis, pulmonary edema, lung disease of prematurity, bronchiolitis obliterans syndrome, and hypersensitivity pneumonitis.
Laboratory, Pulmonary Function, Bronchoscopic Evaluations
Evaluation of a child with severe asthma may include physiological measurements, such as pre- and postbronchodilator spirometry and body plethysmography. It can include assessment of airway inflammation, such as FENO, sputum eosinophils (research tool), bronchoscopy with bronchoalveolar lavage, and bronchial biopsy; and tests for allergic sensitization, such as specific allergen IgE or aeroallergen skin prick tests, or additional evaluation for comorbidities or diseases that mimic asthma (
Comorbidities
Severe asthma in children is associated with several comorbidities, such as obesity, gastroesophageal reflux, dysfunctional breathing, and mental disorders, that may exacerbate the severity of asthma symptoms. Evaluation for these disorders should be considered (Table II).
Evaluation
Analysis of recent research on severe asthma indicates that a structured approach to evaluation and therapy is important.46, 100 First, the child should be assessed for disorders that may mimic asthma (see the Differential Diagnosis section). In 37 young children with severe wheezing unresponsive to therapy, Saglani et al101 found structural abnormalities on bronchoscopy in 36% and evidence of gastroesophageal reflux (an abnormal pH study or lipid-laden macrophages on bronchoalveolar lavage) in
Management, Treatment, Conventional Therapy, Controllers
At present, guideline-based drug therapy of severe childhood asthma is based primarily on extrapolated data from adult studies. The recommendation is that children with severe asthma be treated with higher-dose ICS or oral corticosteroids combined with long-acting β-agonists (LABA) and other add-on therapies.27, 97, 104 Results of some studies showed no evidence of secondary prevention of symptoms and prevention of a decline of lung function,105, 106, 107 whereas, results of other studies
Specific Allergen Immunotherapy
Specific allergen immunotherapy has been demonstrated to have beneficial effects with the management of childhood asthma, including effects on symptom control, medication use, and airway hyperresponsiveness.132 A recent meta-analysis that examined the efficacy of allergen-specific immunotherapy concluded that there is moderate-strength evidence that subcutaneous immunotherapy improves asthma symptoms and high-strength evidence that sublingual immunotherapy improves asthma symptoms.133 However,
Emerging Therapies
Other novel medications for asthma have been studied with adults, and most are considered experimental with children.
Patient Education and Lifestyle Modification
Both national and international asthma guidelines strongly recommend structured asthma education.97, 104 A good dialogue between patients and care providers is encouraged. Moreover, patients may have different ideas from physicians regarding symptom control as well as strong lay beliefs about medications and their adverse effects, which should be addressed. A balance among the degree of asthma control, medication adverse effects, and quality of life should be established. A structured
Conclusions
Although knowledge of asthma and its associated mechanisms has increased substantially over the past decades, significant gaps remain about the determinants of severe asthma in children. It is not clear how the different phenotypes of severe asthma change across time, nor is it clear if these changes are modifiable with appropriate therapy. It is important to identify and address the influences that make asthma difficult to control, including reviewing the diagnosis and the removal of causal or
References (170)
- et al.
Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide
J Allergy Clin Immunol
(2006) - et al.
Severe childhood asthma: a common international approach?
Lancet
(2008) Severe asthma in children. Symposium: Respiratory Medicine
Paediatr Child Health
(2007)- et al.
The importance and features of the distal airways in children and adults
J Allergy Clin Immunol
(2009) - et al.
A comparison of the clinical characteristics of children and adults with severe asthma
Chest
(2003) - et al.
Effect of montelukast on peripheral airflow obstruction in children with asthma
Ann Allergy Asthma Immunol
(2006) - et al.
Sex dependence of airflow limitation and air trapping in children with severe asthma
J Allergy Clin Immunol
(2011) - et al.
Mild to moderate asthma affects lung growth in children and adolescents
J Allergy Clin Immunol
(2006) - et al.
Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure
J Allergy Clin Immunol
(2005) - et al.
Classifying asthma: disagreement among specialists
Chest
(2003)
Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study
Lancet
Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study
Lancet
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma
J Allergy Clin Immunol
Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma
J Allergy Clin Immunol
Predictors of remitting, periodic, and persistent childhood asthma
J Allergy Clin Immunol
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma
J Allergy Clin Immunol
Asthma: defining of the persistent adult phenotypes
Lancet
Phenotype-specific treatment of difficult asthma in children
Paediatr Respir Rev
Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8
Chest
How early do airway inflammation and remodeling occur?
Allergol Int
Inflammatory phenotypes in stable and acute childhood asthma
Paediatr Respir Rev
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Lancet
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines
J Allergy Clin Immunol
The molecular phenotype of severe asthma in children
J Allergy Clin Immunol
Childhood allergic asthma is not a single phenotype
J Pediatr
Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma
J Allergy Clin Immunol
Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2
J Allergy Clin Immunol
Severe Asthma Research Program. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress
J Allergy Clin Immunol
Importance of hedgehog interacting protein and other lung function genes in asthma
J Allergy Clin Immunol
Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients
J Allergy Clin Immunol
FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma
J Allergy Clin Immunol
Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma
J Pediatr
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients
J Allergy Clin Immunol
Management of severe asthma in children
Lancet
Nasal symptoms are associated with school performance in adolescents
J Adolesc Health
Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis
J Allergy Clin Immunol
Vocal cord dysfunction: an update
Ann Allergy Asthma Immunol
The mechanisms, diagnosis, and management of severe asthma in adults
Lancet
Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001–2009
MMWR Morb Mortal Wkly Rep
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma
Eur Respir J
Severe asthma in childhood: assessed in 10 year olds in a birth cohort study
Allergy
Costs of asthma are correlated with severity: a 1-yr prospective study
Eur Respir J
A national estimate of the economic costs of asthma
Am J Respir Crit Care Med
Severe asthma in children: insights from the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program
Pediatr Allergy Immunol Pulmonol
Current asthma guidelines may not identify young children who have experienced significant morbidity
Pediatrics
Risks of long-acting beta-agonists in achieving asthma control
N Engl J Med
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report
Allergy
Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function
Am J Respir Crit Care Med
Is forced expiratory volume in one second the best measure of severity in childhood asthma?
Am J Respir Crit Care Med
Site and nature of airway obstruction in chronic obstructive lung disease
N Engl J Med
Cited by (105)
Assessing Asthma Control by Impulse Oscillometry and Fractional Expiratory Nitric Oxide in Children With Normal Spirometry
2023, Journal of Allergy and Clinical Immunology: In PracticeBioinformatics analysis of ferroptosis-related gene AKR1C3 as a potential biomarker of asthma and its identification in BEAS-2B cells
2023, Computers in Biology and MedicineBiologics in the treatment of asthma in children and adolescents
2023, Journal of Allergy and Clinical ImmunologyAltitude climate treatment in childhood asthma: a vivid and promising approach
2023, Revue Francaise d'Allergologie
No funding was received for this work.
Conflicts of interest: Disclosure of potential conflict of interest: T. Guilbert is on the American Board of Pediatrics and the Pediatric Pulmonary Subboard; has received consultancy fees from Teva, GlaxoSmithKline, and Regeneron Pharmaceuticals; has received research support from the Centers for Disease Control, Department of Health and Human Services (DHHS FAB 20166; T72 MC00008-20-00), National Institutes of Health (NIH), University of Wisconsin Madison Medical and Education Research Committee, Teva, GlaxoSmithKline/Development Limited, CF Foundation Therapeutics, Roche/Genentech, and the NIH; receives royalties from UpToDate; and has received payment for development of educational presentations from Teva. L. B. Bacharier has received consultancy fees from Aerocrine, GlaxoSmithKline, Genentech/Novartis, Merck, Schering, Cephalon, and DBV Technologies; has received research support from the National Heart, Lung, and Blood Institute (NHLBI)/NIH AsthmaNet (NHLBI U10 HL098090; U10 HL109168; P01 HL070831); has received lecture fees from Aerocrine, AstraZeneca, Genentech/Novartis, GlaxoSmithKline, Merck, and Schering. A. M. Fitzpatrick has received research support from the National Institutes of Health, NHLBI (R01 NR012021) and National Institute of Nursing Research (R01 NR013700); has received consultancy fees from MedImmune, Merck Scientific Advisory Board, GlaxoSmithKline Advisory Board, Genentech, and Boehringer Ingelheim.